16 articles for T Yokoyama
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Discovery of (phenoxy-2-hydroxypropyl)piperidines as a novel class of voltage-gated sodium channel 1.7 inhibitors.

Daiichi Sankyo
Structural Insight into the Interactions between Death-Associated Protein Kinase 1 and Natural Flavonoids.

University of Toyama
Inhibitory activities of propolis and its promising component, caffeic acid phenethyl ester, against amyloidogenesis of human transthyretin.

University of Toyama
Development of Benziodarone Analogues with Enhanced Potency for Selective Binding to Transthyretin in Human Plasma.

University of Toyama
Resveratrol Derivatives Inhibit Transthyretin Fibrillization: Structural Insights into the Interactions between Resveratrol Derivatives and Transthyretin.

University of Toyama
Benziodarone and 6-hydroxybenziodarone are potent and selective inhibitors of transthyretin amyloidogenesis.

University of Toyama
-Aryl Indoles as a Novel Class of Potent Na

Daiichi Sankyo
Chlorinated Naringenin Analogues as Potential Inhibitors of Transthyretin Amyloidogenesis.

University of Toyama
Repositioning of the Anthelmintic Drugs Bithionol and Triclabendazole as Transthyretin Amyloidogenesis Inhibitors.

University of Toyama
Inhibitory activities of anthraquinone and xanthone derivatives against transthyretin amyloidogenesis.

University of Toyama
Transthyretin Amyloidogenesis Inhibitors: From Discovery to Current Developments.

University of Toyama
Discovery of DS-1971a, a Potent, Selective Na

Daiichi Sankyo
Crown Ethers as Transthyretin Amyloidogenesis Inhibitors.

University of Toyama
Discovery of a new class of MTH1 inhibitor by X-ray crystallographic screening.

University of Toyama
Effects of 12 Ca2+ antagonists on multidrug resistance, MDR1-mediated transport and MDR1 mRNA expression.

Kyoto Pharmaceutical University
Discovery of novel aminobenzisoxazole derivatives as orally available factor IXa inhibitors.

Mochida Pharmaceutical